Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma

This study aims to evaluate correlations between spleen signal changes in different MRI sequences and bone marrow plasma cell infiltration as potential indicator of disease burden in multiple myeloma (MM) patients. We retrospectively analyzed 45 patients with newly diagnosed MM that underwent whole-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European radiology 2024-11
Hauptverfasser: Neelsen, Christian, Sachpekidis, Christos, John, Lukas, Neher, Peter, Mai, Elias, Grözinger, Martin, Paech, Daniel, Dimitrakopoulou-Strauss, Antonia, Kurz, Felix T, Sauer, Sandra, Raab, Marc S, Schlemmer, Heinz-Peter, Wennmann, Markus, Weinhold, Niels
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title European radiology
container_volume
creator Neelsen, Christian
Sachpekidis, Christos
John, Lukas
Neher, Peter
Mai, Elias
Grözinger, Martin
Paech, Daniel
Dimitrakopoulou-Strauss, Antonia
Kurz, Felix T
Sauer, Sandra
Raab, Marc S
Schlemmer, Heinz-Peter
Wennmann, Markus
Weinhold, Niels
description This study aims to evaluate correlations between spleen signal changes in different MRI sequences and bone marrow plasma cell infiltration as potential indicator of disease burden in multiple myeloma (MM) patients. We retrospectively analyzed 45 patients with newly diagnosed MM that underwent whole-body MRI with axial DWI at b-values 50 (b50) and 800 (b800), and coronal T1 and T2 fast spin-echo (T2-TSE) imaging. A subcohort of 39 patients had concomitant [ F]FDG PET/CT. The spleen was segmented in all MRI sequences and signal intensities were normalized. MR signal intensities and ADC values were correlated with bone marrow plasma cell infiltration from biopsy, laboratory markers (Beta 2-microglobulin, M-Protein, Red blood count (RBC), Hemoglobin, Hematocrit, Total protein, Creatinine), clinical data (ISS stages, high-risk chromosomal aberrations), and standardized uptake value (SUV) in the spleen as well as spleen-to-liver and spleen-to-blood pool SUV ratios on [ F]FDG PET-CT. Bone marrow plasma cell infiltration was negatively correlated with (normalized) mean splenic signal intensity on DWI-b50, DWI-b800, and T2-TSE images (r = -0.64, p 
doi_str_mv 10.1007/s00330-024-11191-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3133736464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3133736464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c228t-ebf0373d2b21dcb2dea066a1a3b35b0f6b4bf739a4347c8870512bb5f34ed11e3</originalsourceid><addsrcrecordid>eNpNkEtLAzEUhYMotlb_gAvJ0s3ovUnmtZTio1ARtC4lJJM7GplHncwg_feOtoqrexbnfHA_xk4RLhAgvQwAUkIEQkWImGOU7bEpKikihEzt_8sTdhTCOwDkqNJDNpF5AiqJYcpentYVNb7gK8GDf21MxX3TUxN8v-FVGwJvG37_uOA-cBNCW3jTk-Ofvn_jzgcygbgdOkfNuOP1UPV-BPJ6Q1Vbm2N2UJoq0MnuztjzzfVqfhctH24X86tlVAiR9RHZEmQqnbACXWGFIwNJYtBIK2MLZWKVLVOZGyVVWmRZCjEKa-NSKnKIJGfsfMtdd-3HQKHXtQ8FVZVpqB2ClihHfqISNVbFtlp043cdlXrd-dp0G42gv7XqrVY9atU_WnU2js52_MHW5P4mvx7lFzi9czU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3133736464</pqid></control><display><type>article</type><title>Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma</title><source>Springer Online Journals Complete</source><creator>Neelsen, Christian ; Sachpekidis, Christos ; John, Lukas ; Neher, Peter ; Mai, Elias ; Grözinger, Martin ; Paech, Daniel ; Dimitrakopoulou-Strauss, Antonia ; Kurz, Felix T ; Sauer, Sandra ; Raab, Marc S ; Schlemmer, Heinz-Peter ; Wennmann, Markus ; Weinhold, Niels</creator><creatorcontrib>Neelsen, Christian ; Sachpekidis, Christos ; John, Lukas ; Neher, Peter ; Mai, Elias ; Grözinger, Martin ; Paech, Daniel ; Dimitrakopoulou-Strauss, Antonia ; Kurz, Felix T ; Sauer, Sandra ; Raab, Marc S ; Schlemmer, Heinz-Peter ; Wennmann, Markus ; Weinhold, Niels</creatorcontrib><description>This study aims to evaluate correlations between spleen signal changes in different MRI sequences and bone marrow plasma cell infiltration as potential indicator of disease burden in multiple myeloma (MM) patients. We retrospectively analyzed 45 patients with newly diagnosed MM that underwent whole-body MRI with axial DWI at b-values 50 (b50) and 800 (b800), and coronal T1 and T2 fast spin-echo (T2-TSE) imaging. A subcohort of 39 patients had concomitant [ F]FDG PET/CT. The spleen was segmented in all MRI sequences and signal intensities were normalized. MR signal intensities and ADC values were correlated with bone marrow plasma cell infiltration from biopsy, laboratory markers (Beta 2-microglobulin, M-Protein, Red blood count (RBC), Hemoglobin, Hematocrit, Total protein, Creatinine), clinical data (ISS stages, high-risk chromosomal aberrations), and standardized uptake value (SUV) in the spleen as well as spleen-to-liver and spleen-to-blood pool SUV ratios on [ F]FDG PET-CT. Bone marrow plasma cell infiltration was negatively correlated with (normalized) mean splenic signal intensity on DWI-b50, DWI-b800, and T2-TSE images (r = -0.64, p &lt; 0.001, r = -0.58, p &lt; 0.001, and r = -0.66, p &lt; 0.001, respectively) while there was no correlation with the apparent diffusion coefficient or spleen size (p = 0.52). In the subgroup analysis of 39 patients with concomitant [ F]FDG PET-CT, there was no correlation of normalized splenic [ F]FDG uptake either with MR spleen signal (for T2 p = 0.64) or with bone marrow plasma cell infiltration (p = 0.37). Our findings reveal a significant association between spleen signal intensity especially on normalized T2-weighted images and tumor burden. Question What changes occur in spleen signal on MRI as tumor load marker changes in multiple myeloma (MM)? Findings Spleen signal intensity, particularly on T2-weighted MRI, negatively correlates with bone marrow plasma cell infiltration and laboratory markers of tumor burden. Clinical relevance Standardized quantification of splenic T2 signal is proposed as a new marker for MM disease burden.</description><identifier>ISSN: 1432-1084</identifier><identifier>EISSN: 1432-1084</identifier><identifier>DOI: 10.1007/s00330-024-11191-8</identifier><identifier>PMID: 39604650</identifier><language>eng</language><publisher>Germany</publisher><ispartof>European radiology, 2024-11</ispartof><rights>2024. The Author(s).</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c228t-ebf0373d2b21dcb2dea066a1a3b35b0f6b4bf739a4347c8870512bb5f34ed11e3</cites><orcidid>0000-0002-1091-8179</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39604650$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Neelsen, Christian</creatorcontrib><creatorcontrib>Sachpekidis, Christos</creatorcontrib><creatorcontrib>John, Lukas</creatorcontrib><creatorcontrib>Neher, Peter</creatorcontrib><creatorcontrib>Mai, Elias</creatorcontrib><creatorcontrib>Grözinger, Martin</creatorcontrib><creatorcontrib>Paech, Daniel</creatorcontrib><creatorcontrib>Dimitrakopoulou-Strauss, Antonia</creatorcontrib><creatorcontrib>Kurz, Felix T</creatorcontrib><creatorcontrib>Sauer, Sandra</creatorcontrib><creatorcontrib>Raab, Marc S</creatorcontrib><creatorcontrib>Schlemmer, Heinz-Peter</creatorcontrib><creatorcontrib>Wennmann, Markus</creatorcontrib><creatorcontrib>Weinhold, Niels</creatorcontrib><title>Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma</title><title>European radiology</title><addtitle>Eur Radiol</addtitle><description>This study aims to evaluate correlations between spleen signal changes in different MRI sequences and bone marrow plasma cell infiltration as potential indicator of disease burden in multiple myeloma (MM) patients. We retrospectively analyzed 45 patients with newly diagnosed MM that underwent whole-body MRI with axial DWI at b-values 50 (b50) and 800 (b800), and coronal T1 and T2 fast spin-echo (T2-TSE) imaging. A subcohort of 39 patients had concomitant [ F]FDG PET/CT. The spleen was segmented in all MRI sequences and signal intensities were normalized. MR signal intensities and ADC values were correlated with bone marrow plasma cell infiltration from biopsy, laboratory markers (Beta 2-microglobulin, M-Protein, Red blood count (RBC), Hemoglobin, Hematocrit, Total protein, Creatinine), clinical data (ISS stages, high-risk chromosomal aberrations), and standardized uptake value (SUV) in the spleen as well as spleen-to-liver and spleen-to-blood pool SUV ratios on [ F]FDG PET-CT. Bone marrow plasma cell infiltration was negatively correlated with (normalized) mean splenic signal intensity on DWI-b50, DWI-b800, and T2-TSE images (r = -0.64, p &lt; 0.001, r = -0.58, p &lt; 0.001, and r = -0.66, p &lt; 0.001, respectively) while there was no correlation with the apparent diffusion coefficient or spleen size (p = 0.52). In the subgroup analysis of 39 patients with concomitant [ F]FDG PET-CT, there was no correlation of normalized splenic [ F]FDG uptake either with MR spleen signal (for T2 p = 0.64) or with bone marrow plasma cell infiltration (p = 0.37). Our findings reveal a significant association between spleen signal intensity especially on normalized T2-weighted images and tumor burden. Question What changes occur in spleen signal on MRI as tumor load marker changes in multiple myeloma (MM)? Findings Spleen signal intensity, particularly on T2-weighted MRI, negatively correlates with bone marrow plasma cell infiltration and laboratory markers of tumor burden. Clinical relevance Standardized quantification of splenic T2 signal is proposed as a new marker for MM disease burden.</description><issn>1432-1084</issn><issn>1432-1084</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkEtLAzEUhYMotlb_gAvJ0s3ovUnmtZTio1ARtC4lJJM7GplHncwg_feOtoqrexbnfHA_xk4RLhAgvQwAUkIEQkWImGOU7bEpKikihEzt_8sTdhTCOwDkqNJDNpF5AiqJYcpentYVNb7gK8GDf21MxX3TUxN8v-FVGwJvG37_uOA-cBNCW3jTk-Ofvn_jzgcygbgdOkfNuOP1UPV-BPJ6Q1Vbm2N2UJoq0MnuztjzzfVqfhctH24X86tlVAiR9RHZEmQqnbACXWGFIwNJYtBIK2MLZWKVLVOZGyVVWmRZCjEKa-NSKnKIJGfsfMtdd-3HQKHXtQ8FVZVpqB2ClihHfqISNVbFtlp043cdlXrd-dp0G42gv7XqrVY9atU_WnU2js52_MHW5P4mvx7lFzi9czU</recordid><startdate>20241127</startdate><enddate>20241127</enddate><creator>Neelsen, Christian</creator><creator>Sachpekidis, Christos</creator><creator>John, Lukas</creator><creator>Neher, Peter</creator><creator>Mai, Elias</creator><creator>Grözinger, Martin</creator><creator>Paech, Daniel</creator><creator>Dimitrakopoulou-Strauss, Antonia</creator><creator>Kurz, Felix T</creator><creator>Sauer, Sandra</creator><creator>Raab, Marc S</creator><creator>Schlemmer, Heinz-Peter</creator><creator>Wennmann, Markus</creator><creator>Weinhold, Niels</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1091-8179</orcidid></search><sort><creationdate>20241127</creationdate><title>Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma</title><author>Neelsen, Christian ; Sachpekidis, Christos ; John, Lukas ; Neher, Peter ; Mai, Elias ; Grözinger, Martin ; Paech, Daniel ; Dimitrakopoulou-Strauss, Antonia ; Kurz, Felix T ; Sauer, Sandra ; Raab, Marc S ; Schlemmer, Heinz-Peter ; Wennmann, Markus ; Weinhold, Niels</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c228t-ebf0373d2b21dcb2dea066a1a3b35b0f6b4bf739a4347c8870512bb5f34ed11e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Neelsen, Christian</creatorcontrib><creatorcontrib>Sachpekidis, Christos</creatorcontrib><creatorcontrib>John, Lukas</creatorcontrib><creatorcontrib>Neher, Peter</creatorcontrib><creatorcontrib>Mai, Elias</creatorcontrib><creatorcontrib>Grözinger, Martin</creatorcontrib><creatorcontrib>Paech, Daniel</creatorcontrib><creatorcontrib>Dimitrakopoulou-Strauss, Antonia</creatorcontrib><creatorcontrib>Kurz, Felix T</creatorcontrib><creatorcontrib>Sauer, Sandra</creatorcontrib><creatorcontrib>Raab, Marc S</creatorcontrib><creatorcontrib>Schlemmer, Heinz-Peter</creatorcontrib><creatorcontrib>Wennmann, Markus</creatorcontrib><creatorcontrib>Weinhold, Niels</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Neelsen, Christian</au><au>Sachpekidis, Christos</au><au>John, Lukas</au><au>Neher, Peter</au><au>Mai, Elias</au><au>Grözinger, Martin</au><au>Paech, Daniel</au><au>Dimitrakopoulou-Strauss, Antonia</au><au>Kurz, Felix T</au><au>Sauer, Sandra</au><au>Raab, Marc S</au><au>Schlemmer, Heinz-Peter</au><au>Wennmann, Markus</au><au>Weinhold, Niels</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma</atitle><jtitle>European radiology</jtitle><addtitle>Eur Radiol</addtitle><date>2024-11-27</date><risdate>2024</risdate><issn>1432-1084</issn><eissn>1432-1084</eissn><abstract>This study aims to evaluate correlations between spleen signal changes in different MRI sequences and bone marrow plasma cell infiltration as potential indicator of disease burden in multiple myeloma (MM) patients. We retrospectively analyzed 45 patients with newly diagnosed MM that underwent whole-body MRI with axial DWI at b-values 50 (b50) and 800 (b800), and coronal T1 and T2 fast spin-echo (T2-TSE) imaging. A subcohort of 39 patients had concomitant [ F]FDG PET/CT. The spleen was segmented in all MRI sequences and signal intensities were normalized. MR signal intensities and ADC values were correlated with bone marrow plasma cell infiltration from biopsy, laboratory markers (Beta 2-microglobulin, M-Protein, Red blood count (RBC), Hemoglobin, Hematocrit, Total protein, Creatinine), clinical data (ISS stages, high-risk chromosomal aberrations), and standardized uptake value (SUV) in the spleen as well as spleen-to-liver and spleen-to-blood pool SUV ratios on [ F]FDG PET-CT. Bone marrow plasma cell infiltration was negatively correlated with (normalized) mean splenic signal intensity on DWI-b50, DWI-b800, and T2-TSE images (r = -0.64, p &lt; 0.001, r = -0.58, p &lt; 0.001, and r = -0.66, p &lt; 0.001, respectively) while there was no correlation with the apparent diffusion coefficient or spleen size (p = 0.52). In the subgroup analysis of 39 patients with concomitant [ F]FDG PET-CT, there was no correlation of normalized splenic [ F]FDG uptake either with MR spleen signal (for T2 p = 0.64) or with bone marrow plasma cell infiltration (p = 0.37). Our findings reveal a significant association between spleen signal intensity especially on normalized T2-weighted images and tumor burden. Question What changes occur in spleen signal on MRI as tumor load marker changes in multiple myeloma (MM)? Findings Spleen signal intensity, particularly on T2-weighted MRI, negatively correlates with bone marrow plasma cell infiltration and laboratory markers of tumor burden. Clinical relevance Standardized quantification of splenic T2 signal is proposed as a new marker for MM disease burden.</abstract><cop>Germany</cop><pmid>39604650</pmid><doi>10.1007/s00330-024-11191-8</doi><orcidid>https://orcid.org/0000-0002-1091-8179</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1432-1084
ispartof European radiology, 2024-11
issn 1432-1084
1432-1084
language eng
recordid cdi_proquest_miscellaneous_3133736464
source Springer Online Journals Complete
title Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T21%3A12%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Splenic%20T2%20signal%20intensity%20loss%20on%20MRI%20is%20associated%20with%20disease%20burden%20in%20multiple%20myeloma&rft.jtitle=European%20radiology&rft.au=Neelsen,%20Christian&rft.date=2024-11-27&rft.issn=1432-1084&rft.eissn=1432-1084&rft_id=info:doi/10.1007/s00330-024-11191-8&rft_dat=%3Cproquest_cross%3E3133736464%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3133736464&rft_id=info:pmid/39604650&rfr_iscdi=true